These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 30539578)

  • 1. Anti-factor H Autoantibodies Assay by ELISA.
    Sénant M; Dragon-Durey MA
    Methods Mol Biol; 2019; 1901():191-196. PubMed ID: 30539578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-factor H autoantibodies assay.
    Dragon-Durey MA; Blanc C; Roumenina LT; Poulain N; Ngo S; Bordereau P; Frémeaux-Bacchi V
    Methods Mol Biol; 2014; 1100():249-56. PubMed ID: 24218265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Standardisation of the factor H autoantibody assay.
    Watson R; Lindner S; Bordereau P; Hunze EM; Tak F; Ngo S; Zipfel PF; Skerka C; Dragon-Durey MA; Marchbank KJ
    Immunobiology; 2014 Jan; 219(1):9-16. PubMed ID: 23891327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An ELISA assay with two monoclonal antibodies allows the estimation of free factor H and identifies patients with acquired deficiency of this complement regulator.
    Nozal P; Garrido S; Alba-Domínguez M; Espinosa L; Peña A; Córdoba SR; Sánchez-Corral P; López-Trascasa M
    Mol Immunol; 2014 Apr; 58(2):194-200. PubMed ID: 24378252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneity but individual constancy of epitopes, isotypes and avidity of factor H autoantibodies in atypical hemolytic uremic syndrome.
    Nozal P; Bernabéu-Herrero ME; Uzonyi B; Szilágyi Á; Hyvärinen S; Prohászka Z; Jokiranta TS; Sánchez-Corral P; López-Trascasa M; Józsi M
    Mol Immunol; 2016 Feb; 70():47-55. PubMed ID: 26703217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-factor H autoantibodies in C3 glomerulopathies and in atypical hemolytic uremic syndrome: one target, two diseases.
    Blanc C; Togarsimalemath SK; Chauvet S; Le Quintrec M; Moulin B; Buchler M; Jokiranta TS; Roumenina LT; Fremeaux-Bacchi V; Dragon-Durey MA
    J Immunol; 2015 Jun; 194(11):5129-38. PubMed ID: 25917093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overall neutralization of complement factor H by autoantibodies in the acute phase of the autoimmune form of atypical hemolytic uremic syndrome.
    Blanc C; Roumenina LT; Ashraf Y; Hyvärinen S; Sethi SK; Ranchin B; Niaudet P; Loirat C; Gulati A; Bagga A; Fridman WH; Sautès-Fridman C; Jokiranta TS; Frémeaux-Bacchi V; Dragon-Durey MA
    J Immunol; 2012 Oct; 189(7):3528-37. PubMed ID: 22922817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-Factor H autoantibodies associated with atypical hemolytic uremic syndrome.
    Dragon-Durey MA; Loirat C; Cloarec S; Macher MA; Blouin J; Nivet H; Weiss L; Fridman WH; Frémeaux-Bacchi V
    J Am Soc Nephrol; 2005 Feb; 16(2):555-63. PubMed ID: 15590760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of Anti-C3b Autoantibodies by ELISA.
    Radanova M; Roumenina LT; Vasilev V
    Methods Mol Biol; 2021; 2227():133-139. PubMed ID: 33847938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of Autoantibodies to Complement Components by Surface Plasmon Resonance-Based Technology.
    Noe R; Chauvet S; Togarsimalemath SK; Marinozzi MC; Radanova M; Vasilev VV; Fremeaux-Bacchi V; Dragon-Durey MA; Roumenina LT
    Methods Mol Biol; 2019; 1901():271-280. PubMed ID: 30539587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoantibodies to complement components in C3 glomerulopathy and atypical hemolytic uremic syndrome.
    Józsi M; Reuter S; Nozal P; López-Trascasa M; Sánchez-Corral P; Prohászka Z; Uzonyi B
    Immunol Lett; 2014 Aug; 160(2):163-71. PubMed ID: 24491679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-factor H autoantibody-associated hemolytic uremic syndrome: review of literature of the autoimmune form of HUS.
    Dragon-Durey MA; Blanc C; Garnier A; Hofer J; Sethi SK; Zimmerhackl LB
    Semin Thromb Hemost; 2010 Sep; 36(6):633-40. PubMed ID: 20865640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atypical hemolytic uremic syndrome due to factor H autoantibody.
    Uslu-Gökceoğlu A; Doğan CS; Comak E; Koyun M; Akman S
    Turk J Pediatr; 2013; 55(1):86-9. PubMed ID: 23692839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factor H Autoantibodies in Patients with Antiphospholipid Syndrome and Thrombosis.
    Foltyn Zadura A; Memon AA; Stojanovich L; Perricone C; Conti F; Valesini G; Bogdanovic G; Hillarp A; Shoenfeld Y; Sundquist J; Leffler J; Svensson PJ; Trouw LA; Blom AM
    J Rheumatol; 2015 Oct; 42(10):1786-93. PubMed ID: 26276971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eculizumab in anti-factor h antibodies associated with atypical hemolytic uremic syndrome.
    Diamante Chiodini B; Davin JC; Corazza F; Khaldi K; Dahan K; Ismaili K; Adams B
    Pediatrics; 2014 Jun; 133(6):e1764-8. PubMed ID: 24843055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An engineered construct combining complement regulatory and surface-recognition domains represents a minimal-size functional factor H.
    Hebecker M; Alba-Domínguez M; Roumenina LT; Reuter S; Hyvärinen S; Dragon-Durey MA; Jokiranta TS; Sánchez-Corral P; Józsi M
    J Immunol; 2013 Jul; 191(2):912-21. PubMed ID: 23772024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemolytic Tests Exploring Factor H Functional Activities.
    Chabannes M; Togarsimalemath SK; Dragon-Durey MA
    Methods Mol Biol; 2021; 2227():69-81. PubMed ID: 33847932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastrointestinal pathogens in anti-FH antibody positive and negative Hemolytic Uremic Syndrome.
    Togarsimalemath SK; Si-Mohammed A; Puraswani M; Gupta A; Vabret A; Liguori S; Mariani-Kurkdjian P; Bagga A; Dragon-Durey MA
    Pediatr Res; 2018 Jul; 84(1):118-124. PubMed ID: 29795200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reference Intervals of Factor H and Factor H-Related Proteins in Healthy Children.
    van Beek AE; Kamp A; Kruithof S; Nieuwenhuys EJ; Wouters D; Jongerius I; Rispens T; Kuijpers TW; Gelderman KA
    Front Immunol; 2018; 9():1727. PubMed ID: 30116238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulse cyclophosphamide therapy and clinical remission in atypical hemolytic uremic syndrome with anti-complement factor H autoantibodies.
    Boyer O; Balzamo E; Charbit M; Biebuyck-Gougé N; Salomon R; Dragon-Durey MA; Frémeaux-Bacchi V; Niaudet P
    Am J Kidney Dis; 2010 May; 55(5):923-7. PubMed ID: 20202729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.